The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
| Image |  |
|---|---|
| Description | scientific article published on 16 May 2015 |
| Author/s |
author: Dario Baratti Daniele Morelli Cecilia Gavazzi Edward Haeusler Marcello Deraco Shigeki Kusamura |
| Publication date | May 16, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |